IJCRR - Vol 07 Issue 13, July, 2015
SERUM MAGNESIUM IN RELATION TO APACHE IV SCORE AND OUTCOME IN CRITICALLY ILL PATIENTS
Author: R. Sudha, S. Bharanidharan
Introduction: Hypomagnesemia is a common but less frequently monitored electrolyte abnormality in hospitalized patients, especially in the critically ill. Accumulating evidence suggests a potential association between magneasium levels and the morbidity and mortality of critically ill patients. Assessment of electrolytes upon admission to the ICU is necessary to identify patients at risk and to guide the appropriate management during ICU stay.
Aims and Objectives:
1. To assess the levels of serum magnesium in critically ill patients on admission.
2. To evaluate its relationship with APACHE IV (Acute Physiology and Chronic Health Evaluation) score, ventilator support and its duration, length of stay, and mortality.
Materials and Methods: 80 patients admitted to the Medical intensive care unit (MICU) were taken for the study. The subjects studied were monitored for serum magnesium levels on Day 1 of intensive care unit (ICU) admission and were followed to assess duration of ventilator support, length of ICU stay and mortality.
Results: At admission, 45% patients had hypomagnesemia, 6% patients had hypermagnesemia and 49% patients had normomagnesemia. Patients with lower magnesium levels had higher need and longer duration of mechanical ventilation, more frequently had hypokalemia, hypocalcemia, hyponatremia and a higher mortality rate (39% vs 25%). APACHE IV score and length of stay did not significantly vary in hypomagnesemic patients.
Conclusion: Since the presence of hypomagnesemia at admission in the ICU patients is associated with a worse prognosis, recognition and treatment of hypomagnesemia in patients entering the ICU are important.
Keywords: Critically ill patients, Serum magnesium, Mortality, APACHE IV, Hypomagnesemia
R. Sudha, S. Bharanidharan. SERUM MAGNESIUM IN RELATION TO APACHE IV SCORE AND OUTCOME IN CRITICALLY ILL PATIENTS International Journal of Current Research and Review. Vol 07 Issue 13, July, 58-61
1. Reinhart RA, Desbiens NA. Hypomagnesemia in patients entering the ICU. Crit Care Med. 1985:13:506-507.
2. Ryzen E, Wagers PW, Singer FR, Rude RK. Magnesium deficiency in a medical ICU population. Crit Care Med. 1985:13:19-21.
3. Deheinzelin D, Negri EM, Tucci MR, Salem MZ, da cruz VM, Oliveira RM, et al. Hypomagnesemia in critically ill cancer patients:a prospective study of predictive factors. Braz J Med Biol Res.2000;33:1443-1448.
4. Zafar MH, Wani JI, Karim R, Mir MM, Koul PA. Significance of serum magnesium levels in critically ill patients. Int J App Basic Med Res 2014;4:34-7.
5. CS Limaye, VA Londhey, MY Nadkar, NE Borges. Hypomagnesemia in critically ill medical patients. JAPI.Jan 2011;59:19-22.
6. Tong GM, Rude RK,. Magnesium deficiency in critical illness. J.Intensiv Care Med 2005;20(1):3-17.
7. Whang R, Oei TO, Aikawa JK, Watanabe A, Vannatta J, Fryer A et al. Predictors of clinical hypomagnesemia:hypokalemia, hypophosphatemia, hyponatremia and hypocalcemia. Arch Intern Med 1984;144:1794-96.
8. Safavi.M, Honarmand A. Admission hypomagnesemia- Impact on mortality and morbidity in critically ill patients. M.E.J.ANESTH. 2007;19(3):645-660.
9. Salem M, Munoz R, Chernow B. Hypomagnesemia in critical illness. Critical care clinics.1991;7:225-252.
10. Michael JD. Hypomagnesemic disorders. Critical care clinics.2001;17:155-173.
11. James W. Van Hook. Hypermagnesemia. Critical care clinics.1991;7:215-223.
12. Burtin P, Bollaert PE, Feldmann L, Lelarge P, Bauer P, Larcan A. Prognosis of patients with stroke undergoing mechanical ventilation. Intensive care Med. 1994;20:32-36.
13. Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health Evaluation (APACHE) IV:ICU length of stay benchmarks for today’s critically ill patients. Crit Care med 2006;34:2517-29.
14. Zimmermann JE, Kramer AA, McNair DS, Malila FM. Acute physiology and chronic health evaluation (APACHE) IV: Hospital mortality assessment for today’s critically ill patients. Crit Care Med 2006;34(5):1297-310.
15. Tulin Akarsu Ayazoglu. A comparison of APACHE II and APACHE IV scoring systems in predicting outcome in patients admitted with stroke to an intensive care unit. Anaesth, Pain & Intensive care.2011;15(1):7-12.
16. Rubeiz GJ, Thill Baharozian M, Hardie D, Carlson RW. Association of hypomagnesemia and mortality in acutely ill medical patients. Crit care med. 1993;21:203-209.
17. Soliman HM, Mercan D, Lobo SS, Melot C, Vincent JL. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit care med.2003;31:1082- 1087.
18. Cohen N, Almoznino-Sarafian D, Zaidenstein R, Alon I, Gorelik O, Shteinshnaider M et al. Serum magnesium aberrations in furosemide treated patients with congestive heart failure; pathophysiological correlates and prognostic evaluation. Heart.2003;89:411-416.
19. Kevin J.Martin, Esther A. Gonsalez, Eduardo Slatopolsky. Clinical consequences and management of hypomagnesemia. J Am soc Nephrol.2009;20:2291-2295.
20. Guerin C, Cousin C. Serum and erythrocyte magnesium in critically ill patients. Intensive Care Med.1996;22:724-727.
21. Mario barbagallo, Ligia J Dominguez. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Archives of Biochemistry and Biophysics.2007 Feb 1;458(1):40-7
22. Chernow B, Bamberger S, Stoiko M, Vadnais M, Mills S, Hoellerich V et al. Hypomagnesemia in patients in postoperative intensive care unit. Chest 1989;95:391-397.
23. Subhraprakashpramanik, Arpan kumar Dey, Pijushkantimandal,Shovan Kumar Das, Debashishghosh, Arpan Bhattacharya, Milan Chakroborty, Somnathdasgupta. Prevalence of hypomagnesemia and its predictive prognostic value in critically ill medical patients. IOSR Journal of Pharmacy.2014;4(1):1-5.
24. Escuela MP, Guerra M, Anon JM, Martinez-Vizcaino V, Zapatero MD, Garcia-Jalon A et al. Total and ionized serum magnesium in critically ill patients. Intensive care med.2005;31(1):151-6.